Bruker Corporation (BRKR) Stock Score, Valuation & Financial Research
Bruker Corporation is in the Healthcare sector and Medical - Devices industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 23/100.
Quick answer for BRKR
Bruker Corporation currently has a Wall Street Score of 23/100. The stored market price is $52.66. Its financial score is 25/100. Its valuation score is 0/100. The latest WSS change is -0.1 points. These figures are a research snapshot, not a buy or sell recommendation.
What Bruker Corporation does
Bruker Corporation stands as a prominent global developer, manufacturer, and distributor of cutting-edge scientific instruments, alongside comprehensive analytical and diagnostic solutions. Its operations are structured across three distinct segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. The company's extensive portfolio for life sciences encompasses a variety of advanced tools, including single and multi-modality systems, sophisticated mass spectrometry platforms, and critical diagnostic solutions. These diagnostics feature the acclaimed MALDI Biotyper for swift pathogen identification, various molecular diagnostic kits (such as genotype and fluorotype offerings), DNA test strips, and fluorescence-based polymerase chain reaction (PCR) technology, notably including SARS-CoV-2 testing solutions for COVID-19 diagnosis and Fl
BRKR financial snapshot
- Wall Street Score:
- 23/100
- Current price:
- $52.66
- Market capitalization:
- $8.02B
- Revenue:
- $3.50B
- Net income:
- $-71.2M
- Free cash flow:
- $13.9M
- Cash:
- $184.9M
- Total debt:
- $1.92B
- EPS:
- -0.70
- Financial score:
- 25/100
- Valuation score:
- 0/100
- Revenue score:
- 12/100
What stands out
- Reported year-over-year revenue growth is +0.0%.
- Free cash flow is $13.9M, showing positive cash generation.
- The balance sheet shows $184.9M of cash versus $1.92B of total debt, so leverage deserves attention.
- The latest Wall Street Score change is -0.1 points: BRKR decreased 0.1 points because some fundamentals weakened.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 25/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-09.
How to research BRKR
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.